Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-10-02 Purchase(A) | 2023-10-05 8:39 pm | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 10,000 | $2.4116 | $24,116 | 25,000 (Direct) | View |
2023-10-02 Purchase | 2023-10-04 6:10 pm | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 10,000 | $2.4116 | $24,116 | 20,000 (Direct) | View |
2022-12-15 Purchase | 2022-12-16 7:30 pm | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 15,000 | $0.51 | $7,650 | 150,000 (Direct) | View |
2022-12-12 Purchase | 2022-12-13 11:44 am | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 10,000 | $0.61 | $6,100 | 135,000 (Direct) | View |
2022-11-14 Purchase | 2022-11-15 7:44 pm | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 52,500 | $0.53 | $27,825 | 125,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-30 Option Award | 2024-10-29 5:42 pm | 2024-09-30 2029-09-30 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 5,304 | $0 | 19,453 (Direct) | View |
2024-07-03 Option Award | 2024-07-05 4:16 pm | 2024-06-30 2029-06-30 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 14,149 | $0 | 14,149 (Direct) | View |
Ownership | 2022-07-28 4:18 pm | N/A N/A | LIXTE BIOTECHNOLOGY HOLDINGS INC. | LIXT | Bernards Rene Director | 0 | $0 | 72,500 (Direct) | View |